KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Aurinia Pharmaceuticals (AUPH) Amortization - Intangibles (2020 - 2021)

Aurinia Pharmaceuticals (AUPH) has disclosed Amortization - Intangibles for 2 consecutive years, with $1.2 million as the latest value for Q4 2021.

  • For the quarter ending Q4 2021, Amortization - Intangibles changed N/A year-over-year to $1.2 million, compared with a TTM value of $2.5 million through Dec 2021, changed N/A, and an annual FY2021 reading of $2.1 million, up 62.76% over the prior year.
  • Amortization - Intangibles was $1.2 million for Q4 2021 at Aurinia Pharmaceuticals, up from $517000.0 in the prior quarter.
  • Across five years, Amortization - Intangibles topped out at $1.2 million in Q4 2021 and bottomed at $300000.0 in Q1 2020.